Mutya Harsch
Overview
Mutya Harsch received an average of $1M in total compensation, including $382K in salary, at VYNE Therapeutics from 2020 to 2023.
2023VYNE TherapeuticsChief Legal Officer, General Counsel and Secretary
2022VYNE TherapeuticsChief Legal Officer, General Counsel and Secretary
2021VYNE TherapeuticsChief Legal Officer, General Counsel and Secretary
2020VYNE TherapeuticsChief Legal Officer, General Counsel and Secretary
Source: SEC filings on November 12, 2024, November 13, 2023, June 17, 2022, and June 7, 2021.
Related executives
We found seven more executives who work or worked at VYNE Therapeutics.
David Domzalski
VYNE Therapeutics
Chief Executive Officer
Iain Stuart
VYNE Therapeutics
Chief Scientific Officer
Steven Basta
VYNE Therapeutics
Chief Executive Officer
Andrew Saik
VYNE Therapeutics
Chief Financial Officer
Kristine Ball
VYNE Therapeutics
Chief Financial Officer
Paul Kwon
VYNE Therapeutics
Chief Scientific Officer
Mary Spellman
VYNE Therapeutics
Chief Medical Officer
News
VYNE Therapeutics CEO David Domzalski's 2023 pay jumps 110% to $2.7M
November 12, 2024
VYNE Therapeutics CEO David Domzalski's 2022 pay falls 73% to $1.3M
November 13, 2023
VYNE Therapeutics CEO David Domzalski's 2021 pay jumps 69% to $4.9M
June 17, 2022
VYNE Therapeutics CEO David Domzalski receives $2.9M in 2020
June 7, 2021